Analysis of Prognosis and Patient Reported Outcomes in Lung Transplant Candidates
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 272
- Locations
- 4
- Primary Endpoint
- Prognosis/Mortality
Study Overview
Brief Summary
The purposes of the study are (1) to analyze the baseline patient characteristics cross-sectionally, (2) to analyze the prognosis and its predictive factors and (3) to examine the longitudinal clinical course in the lung transplant candidates in Japan.
Detailed Description
The significance of assessing patient reported measurements including health status, dyspnea and psychological status has not been well investigated in the lung transplant candidates. Therefore, in the present study, we aim to examine (1) contributive factors to their health status based on baseline data, (2) whether patient reported measurements would predict patients' prognosis and (3) how they would change for 5 years as compared to physiological measurements.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 16 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •New lung transplant candidates
Exclusion Criteria
- •Heart and lung transplant candidates
- •Uncontrolled severe comorbidities
Outcomes
Primary Outcomes
Prognosis/Mortality
Time Frame: 5 years
Secondary Outcomes
- Arterial blood gas(At entry and every year for 5 years)
- Health status(At entry and every year for 5 years)
- Dyspnea(At entry and every year for 5 years)
- Psychological status(At entry and every year for 5 years)
- Sleep quality(At entry and every year for 5 years)
- Pulmonary function(At entry and every year for 5 years)
Investigators
Toru Oga
Respiratory Care and Sleep Control Medicine, Kyoto University, Graduate School of Medicine
Kyoto University, Graduate School of Medicine